Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that specific itchy skin diseases during pregnancy have varying fetal risks and treatments, including corticosteroids and other medications.

Taking 5α-reductase inhibitors with prednisolone can worsen its negative effects on metabolism.

The research found that MRI and certain hormone levels can help tell apart ovarian tumors from hyperthecosis in postmenopausal women, but tissue analysis is still needed for a definite diagnosis.

Early hair loss may be linked to metabolic syndrome.

Medications for PCOS don't seem to raise heart disease risk.

Hormone therapy is essential for transgender individuals but requires careful management due to possible metabolic effects.

DNA variants can predict male pattern baldness, with higher risk scores increasing baldness likelihood.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

Acupuncture may improve reproductive and metabolic functions in PCOS without negative side effects, but more research is needed to confirm its effectiveness.

Vav2 changes how hair follicle stem cells' genes work as they age, which might improve regeneration but also raise cancer risk.

Women with hair loss have higher heart disease risk and unhealthy cholesterol levels.

Disrupting natural body clocks increases the risk of developing type 2 diabetes.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Young adults with hair loss face higher risk of stiff arteries.

Rare changes in the KRT82 gene are linked to a higher risk of Alopecia Areata.

People with alopecia have a higher risk of thyroid cancer.

FPHL common in Taiwanese women; risk factors include BMI, high glucose, early puberty, fewer childbirths, oral contraceptives, and UV exposure.

DHT is a strong androgen that may pose less risk to the prostate compared to testosterone.

Treating early puberty with hormone therapy may increase the risk of polycystic ovary syndrome in adults.

Pregnant women with Systemic Lupus Erythematosus have a higher risk of blood clotting problems.

Certain genetic variations in the SHBG gene are linked to an increased or decreased risk of PCOS in Mediterranean women.

Premature balding in some men may be linked to altered hormones, but it's not the male equivalent to polycystic ovary syndrome or metabolic syndrome.

The document concludes that parathyroid diseases have a range of clinical features and outcomes, with some conditions being treatable and others having a high risk of mortality.

People with PCOS have higher levels of PAI-1, which may increase their risk of heart disease and fertility issues.

Skin problems like excessive hair growth, acne, and dark skin patches can be signs of Polycystic Ovarian Disease, which may also be linked to family history and a risk for diabetes.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

The study developed a tool to predict how gut microbes process foods and drugs, showing that similar compounds often share metabolic pathways and effects.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

Women with AGA have higher lipid levels, increasing heart disease risk.

Insulin resistance is found in 20% of Thai women with PCOS, with age, waist size, skin changes, and abnormal blood fats increasing the risk.